Last update :
29/10/2024
Antihypertensive   Hydralazine hydrochloride  
Oral solution
injection
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Hydralazine hydrochloride     
Container Origine excipient Temperature Storage Duration of stability References
Glass powder 100 mg
Sorbitol 70% 40g
methylparaben 65 mg
Propylparaben 35 mg
propylene glycol 10 g
aspartame 50 mg
Purified water >> 100 ml
5°C Protect from light
30 Day
2836

Glass powder 1000 mg
Sorbitol 70% 40g
methylparaben 65 mg
Propylparaben 35 mg
propylene glycol 10 g
aspartame 50 mg
Purified water >> 100 ml
5°C Protect from light
30 Day
2836

plastic bottle powder 600 mg
® = ?
SyrSpend SF PH4® >> 150 mL
2-8°C Protect from light
30 Day
4408

plastic bottle powder 600 mg
® = ?
SyrSpend SF PH4® >> 150 mL
20-25°C Protect from light
30 Day
4408

plastic bottle tablets 480 mg
®= (Rugby Laboratories)
OraPlus® / OraSweet® (1:1) >> 120 ml
5°C Protect from light
24 Hour
2422

plastic bottle tablets 480 mg
®= (Rugby Laboratories)
OraPlus® / OraSweet SF® (1:1) >> 120 ml
5°C Protect from light
48 Hour
2422

plastic bottle powder 100 mg
Sorbitol 70% 40g
methylparaben 65 mg
Propylparaben 35 mg
propylene glycol 10 g
aspartame 50 mg
Purified water >> 100 ml
5°C Protect from light
30 Day
2836

plastic bottle powder 1000 mg
Sorbitol 70% 40g
methylparaben 65 mg
Propylparaben 35 mg
propylene glycol 10 g
aspartame 50 mg
Purified water >> 100 ml
5°C Protect from light
30 Day
2836


  Mentions Légales